# A Study of SSS17 in Healthy Subjects

> **NCT04317833** · PHASE1 · UNKNOWN · sponsor: **Shenyang Sunshine Pharmaceutical Co., LTD.** · enrollment: 65 (estimated)

## Conditions studied

- Anemia in Chronic Kidney Diseases

## Interventions

- **DRUG:** SSS17
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04317833
- **Lead sponsor:** Shenyang Sunshine Pharmaceutical Co., LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-05-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-12-31
- **Target enrollment:** 65 (ESTIMATED)
- **Last updated:** 2020-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04317833

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04317833, "A Study of SSS17 in Healthy Subjects". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04317833. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*